Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Streamex Corp.BSGM · Entity 1816 | Chief Financial Officer | February 16, 2023 | February 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Streamex Corp.
Report date February 16, 2023 · Filed February 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2033-02-15 | Direct | 250,000 |
Reported balance
After 2023-02-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-02-16 · Grant · Acquired 250,000 · Balance 250,000 F1: The stock options shall have a quarterly vesting schedule and shall become exercisable as of the date they vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options shall have a quarterly vesting schedule and shall become exercisable as of the date they vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2023 Filed Feb 17, 2023 15:03 UTC | Streamex Corp. BSGM · Entity 1816 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001185185-23-000146 · ownership.xml · derivative · entry 1 BUHALY STEVEN J · CIK 0001253097 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2033-02-15 F1 · derivative.exercise_date: The stock options shall have a quarterly vesting schedule and shall become exercisable as of the date they vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person. Read SEC document |
| February 08, 2023 Filed Feb 8, 2023 12:25 UTC | Streamex Corp. BSGM · Entity 1816 | PurchaseWarrants (right to buy) · Derivative | 116,441 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001185185-23-000106 · ownership.xml · derivative · entry 2 BUHALY STEVEN J · CIK 0001253097 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,441 Underlying: Common Stock · 116,441 shares Expires 2028-08-08 F1 · price: The combined purchase price for a share of common stock and the accompanying warrant to purchase 0.5 of a share was $0.8588. Read SEC document |
| February 08, 2023 Filed Feb 8, 2023 12:25 UTC | Streamex Corp. BSGM · Entity 1816 | PurchaseCommon Stock | 232,882 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001185185-23-000106 · ownership.xml · nonDerivative · entry 1 BUHALY STEVEN J · CIK 0001253097 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,882 F1 · price: The combined purchase price for a share of common stock and the accompanying warrant to purchase 0.5 of a share was $0.8588. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.